PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - XT Intermediate and High Risk

Trial ID or NCT#



not recruiting iconNOT RECRUITING


The purpose of this trial is to determine the safety and effectiveness of the Edwards SAPIEN XT transcatheter heart valve and delivery systems which are intended for use in patients with symptomatic, calcific, severe aortic stenosis.

Official Title

Edwards SAPIEN XT Transcatheter Heart Valve Therapy for Intermediate and High Risk Patients

Eligibility Criteria

Sexes Eligible for Study: All
Accepts Healthy Volunteers: No


D. Craig Miller, M.D.
Rajesh Dash, MD PhD;      Director of SSATHI & CardioClick
Rajesh Dash, MD PhD; Director of SSATHI & CardioClick
Associate Professor of Medicine (Cardiovascular Medicine)
Alan Yeung, MD
Alan Yeung, MD
Interventional cardiologist, Cardiologist
Li Ka Shing Professor in Cardiology

Contact us to find out if this trial is right for you.


Martina Kelly Speight